2021
Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application
Buono FD, Lalloo C, Larkin K, Zempsky WT, Ball S, Grau LE, Pham Q, Stinson J. Innovation in the treatment of persistent pain in adults with Neurofibromatosis Type 1 (NF1): Implementation of the iCanCope mobile application. Contemporary Clinical Trials Communications 2021, 25: 100883. PMID: 35036627, PMCID: PMC8743203, DOI: 10.1016/j.conctc.2021.100883.Peer-Reviewed Original ResearchNeurofibromatosis type 1Pain symptomsNF1 populationType 1Chronic pain symptomsSelf-management treatmentPersistent painTreatment satisfactionTreatment optionsControl studySix weeksPainPsychometric evaluationContingency managementInitial effectivenessGenetic disordersThird groupSymptomsAdultsTreatmentPopulationDifferent populationsGroupParticipants' experiencesGreater reach
2007
Issues in Designing and Implementing a Spanish‐Language Multi‐Site Clinical Trial
Suarez‐Morales L, Matthews J, Martino S, Ball SA, Rosa C, Farentinos C, Szapocznik J, Carroll KM. Issues in Designing and Implementing a Spanish‐Language Multi‐Site Clinical Trial. American Journal On Addictions 2007, 16: 206-215. PMID: 17612825, PMCID: PMC3628724, DOI: 10.1080/10550490701375707.Peer-Reviewed Original ResearchConceptsClinical trialsMulti-site clinical trialClinical Trials NetworkNIDA Clinical Trials NetworkMotivational enhancement therapySubstance abuse treatmentMulti-site trialClinical staffHealth disparitiesTrials NetworkAbuse treatmentEnhancement therapyTrialsHispanic populationStudy teamAssessment instrumentsDiverse populationsPopulationTherapy